- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股进入多头行情中，股价短线上涨概率较大。
- 中期趋势：
回落整理中且下跌有加速趋势。
- 长期趋势：
已有2家主力机构披露2025-06-30报告期持股数据，持仓量总计1.25亿股，占流通A股14.18%
- 波段诊断：
-
技术面诊股
诊断结果：6.6技术面打败了46%的股票
技术面评分前10的股票
近期的平均成本为5.92元。多头行情中，目前处于回落整理阶段且下跌有加速趋势。
平均成本
近期的平均成本为5.92元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.92","date":1760428520,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2025.10.15","stock":"2.07","trade":"2.81","ind":"1.73"},{"date":"2025.10.14","stock":"-0.68","trade":"-1.22","ind":"-2.54"},{"date":"2025.10.13","stock":"-1.35","trade":"-0.84","ind":"-0.93"},{"date":"2025.10.10","stock":"0.68","trade":"-0.24","ind":"-2.70"},{"date":"2025.10.09","stock":"-0.67","trade":"-0.39","ind":"1.47"},{"date":"2025.09.30","stock":"1.19","trade":"0.72","ind":"0.35"},{"date":"2025.09.29","stock":"-0.51","trade":"-0.14","ind":"2.05"},{"date":"2025.09.26","stock":"0.17","trade":"-1.67","ind":"-1.76"},{"date":"2025.09.25","stock":"-0.17","trade":"-0.91","ind":"0.67"},{"date":"2025.09.24","stock":"1.20","trade":"1.94","ind":"1.80"},{"date":"2025.09.23","stock":"-1.02","trade":"-1.95","ind":"-0.29"},{"date":"2025.09.22","stock":"-1.01","trade":"-0.40","ind":"0.67"},{"date":"2025.09.19","stock":"1.37","trade":"-1.50","ind":"-0.04"},{"date":"2025.09.18","stock":"-1.68","trade":"-0.61","ind":"-1.06"},{"date":"2025.09.17","stock":"2.41","trade":"-0.67","ind":"1.16"},{"date":"2025.09.16","stock":"-0.34","trade":"-0.09","ind":"0.45"},{"date":"2025.09.15","stock":"-1.18","trade":"-0.14","ind":"0.63"},{"date":"2025.09.12","stock":"3.68","trade":"0.60","ind":"-0.43"},{"date":"2025.09.11","stock":"-1.21","trade":"0.29","ind":"3.36"},{"date":"2025.09.10","stock":"0.35","trade":"-0.63","ind":"0.38"},{"date":"2025.09.09","stock":"-1.54","trade":"-1.92","ind":"-1.23"}]
ST景峰,深证成指,化学制药指数
压力支撑
该股压力位为5.87元，支撑位为5.72元。
[{"text":"\u538b\u529b\u4f4d","value":"5.87","date":1760457600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.72","date":1760457600,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌有加速趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.3资金面打败了35%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月15日 20:31
| 机构今日流向(万元) | 2636.06 | 机构5日流向(万元) | -5376.22 |
| 机构10日流向(万元) | -7183.91 | 机构20日流向(万元) | -22872.17 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量不变，其中基金数没有增加，主力数没有增加，暂未发现中长期投资价值。
截止2025-06-30，共2家主力机构（一般法人2家），持仓量总计12476.41万股，占流通A股14.18%
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：0家 ，原持有万股
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：0家 ，原持有万股
消息面诊股
诊断结果：5.4消息面打败了9%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- ST景峰：控股股东叶湘武解除质押1700万股
2025-09-25 - ST风暴席卷A股：159家公司“戴帽”，计算机、医
2025-09-24 - ST景峰：公司能否进入重整程序尚存在不确定性
2025-09-04 - 【龙虎榜】 ST景峰 9月4日成交明细
2025-09-04 - ST景峰09月03日涨停分析
2025-09-03 - 涨停雷达：创新药+心脑血管+骨科+抗肿瘤 ST景峰
2025-09-03 - 股东追踪|赵建锋新进ST景峰前十大流通股东
2025-08-24 - ST景峰（截止2025年6月30日）股东人数为31
2025-08-24 - 财报速递：ST景峰2025年半年度净亏损3256.
2025-08-27 - ST景峰主力资金持续净流入，3日共净流入1537.
2025-08-22
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2025-10-09 |
| 一般消息 | 重大事项 | 关联交易 | 2025-10-09 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-25 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-07-22 |
| 一般消息 | 重大事项 | 公司股东股份冻结 | 2025-07-22 |
| 重大利空 | 业绩预告 | 预计续亏 | 2025-07-15 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 上市变动 | 公司摘* | 2025-06-16 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-05-30 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-05-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-30 |
| 一般消息 | 高管变动 | 因工作分工调整 | 2025-05-28 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-05-20 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-29 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-25 |
| 一般消息 | 高管变动 | 因达到法定退休年龄 | 2025-04-24 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-02-15 |
| 利好 | 业绩预告 | 预计扭亏 | 2025-01-22 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 高管变动 | 自身工作繁忙 | 2024-12-17 |
| 一般消息 | 重大事项 | 关联交易 | 2024-11-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-11-26 |
| 一般消息 | 重大事项 | 关联交易 | 2024-11-05 |
| 一般消息 | 重大事项 | 关联交易 | 2024-10-19 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：5.7行业面打败了72%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.10.15","price":"1.73","value":"2.81"},{"date":"2025.10.14","price":"-2.54","value":"-1.22"},{"date":"2025.10.13","price":"-0.93","value":"-0.84"},{"date":"2025.10.10","price":"-2.70","value":"-0.24"},{"date":"2025.10.09","price":"1.47","value":"-0.39"},{"date":"2025.09.30","price":"0.35","value":"0.72"},{"date":"2025.09.29","price":"2.05","value":"-0.14"},{"date":"2025.09.26","price":"-1.76","value":"-1.67"},{"date":"2025.09.25","price":"0.67","value":"-0.91"},{"date":"2025.09.24","price":"1.80","value":"1.94"},{"date":"2025.09.23","price":"-0.29","value":"-1.95"},{"date":"2025.09.22","price":"0.67","value":"-0.40"},{"date":"2025.09.19","price":"-0.04","value":"-1.50"},{"date":"2025.09.18","price":"-1.06","value":"-0.61"},{"date":"2025.09.17","price":"1.16","value":"-0.67"},{"date":"2025.09.16","price":"0.45","value":"-0.09"},{"date":"2025.09.15","price":"0.63","value":"-0.14"},{"date":"2025.09.12","price":"-0.43","value":"0.60"},{"date":"2025.09.11","price":"3.36","value":"0.29"},{"date":"2025.09.10","price":"0.38","value":"-0.63"},{"date":"2025.09.09","price":"-1.23","value":"-1.92"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 向日葵 | 101.24% | 6.01% | 5.3分 |
| 2 | 多瑞医药 | 20.27% | 7.57% | 5.9分 |
| 3 | 宏源药业 | 12.77% | 19.26% | 5.0分 |
| 4 | 广生堂 | 10.93% | 21.32% | 6.0分 |
| 5 | 康芝药业 | 10.09% | 0.70% | 6.0分 |
| 6 | 华纳药厂 | 9.32% | 5.81% | 6.5分 |
| 8 | 常山药业 | 6.31% | 10.21% | 6.1分 |
| 10 | 通化金马 | 4.67% | -1.88% | 4.5分 |
| 12 | 永安药业 | 3.33% | 8.13% | 5.1分 |
| 14 | ST景峰 | 3.13% | 0.00% | 5.3分 |
| 16 | 圣诺生物 | 2.34% | 0.29% | 7.0分 |
| 18 | 福元医药 | 1.70% | 4.34% | 6.8分 |
| 20 | 仟源医药 | 0.93% | 3.02% | 6.3分 |
| 22 | 前沿生物 | 0.68% | 2.56% | 5.2分 |
| 24 | 海正药业 | 0.10% | 0.67% | 6.1分 |
| 26 | 立方制药 | -0.31% | 3.35% | 6.4分 |
| 28 | 辰欣药业 | -0.53% | 2.11% | 5.9分 |
| 30 | 华润双鹤 | -0.72% | 3.00% | 6.4分 |
| 32 | 莱美药业 | -0.88% | 4.67% | 6.3分 |
| 34 | 富祥药业 | -1.16% | 2.41% | 4.6分 |
| 36 | 哈药股份 | -1.35% | 2.24% | 6.3分 |
| 38 | 中关村 | -1.49% | 0.38% | 6.3分 |
| 40 | 易明医药 | -1.56% | -1.97% | 4.5分 |
| 42 | - | -1.78% | 4.19% | 分 |
| 44 | 花园生物 | -1.95% | -0.28% | 6.0分 |
| 46 | 宣泰医药 | -2.09% | -1.56% | 6.1分 |
| 48 | 民生健康 | -2.24% | 1.30% | 5.9分 |
| 50 | 德展健康 | -2.37% | -6.15% | 4.6分 |
| 52 | 津药药业 | -2.58% | 2.72% | 6.1分 |
| 54 | 润都股份 | -2.72% | 4.29% | 5.7分 |
| 56 | 九典制药 | -2.76% | 4.86% | 6.0分 |
| 58 | 双鹭药业 | -2.77% | 2.36% | 6.3分 |
| 60 | 恩华药业 | -2.88% | -4.49% | 4.9分 |
| 62 | 丰原药业 | -3.23% | 2.01% | 6.1分 |
| 64 | 金陵药业 | -3.46% | 1.75% | 6.3分 |
| 66 | 国药现代 | -3.57% | 1.69% | 6.2分 |
| 68 | 川宁生物 | -3.63% | 3.34% | 5.9分 |
| 70 | 苑东生物 | -4.14% | -3.00% | 5.4分 |
| 72 | 浙江医药 | -4.40% | 2.75% | 6.3分 |
| 74 | 奥锐特 | -4.47% | 0.04% | 6.4分 |
| 76 | 本立科技 | -4.51% | 1.14% | 5.9分 |
| 78 | 华邦健康 | -4.59% | 0.44% | 6.5分 |
| 80 | 华仁药业 | -4.68% | 0.31% | 6.3分 |
| 82 | 赛分科技 | -4.74% | -3.77% | 5.3分 |
| 84 | 广济药业 | -5.18% | 1.91% | 6.3分 |
| 86 | 誉衡药业 | -5.57% | 4.21% | 6.7分 |
| 88 | 卫信康 | -5.61% | 2.31% | 6.4分 |
| 90 | 小方制药 | -5.94% | -0.39% | 5.4分 |
| 92 | 百利天恒 | -6.05% | -9.33% | 5.3分 |
| 94 | 联环药业 | -6.32% | 9.42% | 6.6分 |
| 96 | 海南海药 | -6.42% | 0.73% | 5.4分 |
| 98 | 丽珠集团 | -6.60% | -1.40% | 5.2分 |
| 100 | - | -6.63% | 2.58% | 分 |
| 102 | - | -6.88% | 0.36% | 分 |
| 104 | 灵康药业 | -7.07% | -1.46% | 5.4分 |
| 106 | 亿帆医药 | -7.28% | 0.94% | 6.1分 |
| 108 | 京新药业 | -7.35% | -11.15% | 5.0分 |
| 110 | 艾力斯 | -7.56% | -3.61% | 6.3分 |
| 112 | 司太立 | -7.77% | 2.48% | 6.3分 |
| 114 | 人福医药 | -8.03% | 0.47% | 6.0分 |
| 116 | ST诺泰 | -8.37% | -9.93% | 4.9分 |
| 118 | 奥翔药业 | -8.48% | -0.59% | 5.6分 |
| 120 | 吉贝尔 | -8.53% | -6.86% | 5.5分 |
| 122 | 海普瑞 | -8.73% | -1.25% | 5.5分 |
| 124 | - | -8.78% | 2.24% | 分 |
| 126 | 罗欣药业 | -9.37% | 0.80% | 5.3分 |
| 128 | 美诺华 | -9.41% | 3.59% | 5.5分 |
| 130 | 汇宇制药 | -9.76% | -1.72% | 5.3分 |
| 132 | 首药控股 | -10.02% | -10.78% | 4.7分 |
| 134 | 天宇股份 | -10.41% | -4.88% | 4.3分 |
| 136 | 科伦药业 | -11.11% | -5.25% | 4.9分 |
| 138 | 微芯生物 | -12.07% | -5.08% | 5.5分 |
| 140 | 奥赛康 | -12.39% | -6.51% | 5.1分 |
| 142 | - | -12.99% | 0.72% | 分 |
| 144 | 迪哲医药 | -13.86% | -12.59% | 5.5分 |
| 146 | 华海药业 | -14.89% | -2.36% | 5.1分 |
| 148 | 金城医药 | -16.84% | -4.95% | 4.9分 |
| 150 | 一品红 | -18.86% | -6.39% | 4.7分 |
| 152 | 贝达药业 | -20.59% | -13.35% | 4.8分 |
| 154 | 新诺威 | -26.90% | -7.16% | 4.7分 |
| 156 | 南新制药 | -36.22% | -27.53% | 5.1分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投 | 2012-09-10 | 增持 | 增持 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 申银万国 | 2012-09-10 | 增持 | 增持 |
| 国都证券 | 2012-09-10 | 增持 | - |
| 长江证券 | 2012-09-09 | 增持 | 增持 |
更多>>行业资讯
- 2012-09-13科达机电稳步上涨 3大业务或刺激业绩大增
- 2012-09-13二重重装职工董事辞职及增补职工董事
- 2012-09-13凤凰光学修订<公司章程>部分条款
- 2012-09-13南通锻压：使用募集资金对南通锻压设备（天津）有限公
- 2012-09-13华中数控：重大资产重组进展
- 2012-09-13华西能源：获得中国证监会核准公开发行公司债券批复
- 2012-09-13海源机械：持股5%以上股东减持股份
- 2012-09-13中原内配：通过德国DaimlerAG（戴姆勒有限公
- 2012-09-13杰瑞股份：重大事项停牌
- 2012-09-13航天科技：股票交易异常波动
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 147/218 ， 37/218。
[{"date":"2025-06-30","value":"-49.70","vol":"1.40"},{"date":"2025-03-31","value":"-15.69","vol":"-0.17"},{"date":"2024-12-31","value":"2684.86","vol":"19.77"},{"date":"2024-09-30","value":"","vol":"4.61"},{"date":"2024-06-30","value":"","vol":"3.55"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-49.70 | -15.69 | 2684.86 | - | - |
| 行业(%) | 1.40 | -0.17 | 19.77 | 4.61 | 3.55 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"65.33","vol":"49.76"},{"date":"2025-03-31","value":"66.62","vol":"49.23"},{"date":"2024-12-31","value":"62.80","vol":"51.11"},{"date":"2024-09-30","value":"59.93","vol":"50.51"},{"date":"2024-06-30","value":"62.94","vol":"50.85"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
65.33 | 66.62 | 62.80 | 59.93 | 62.94 |
| 行业(%) | 49.76 | 49.23 | 51.11 | 50.51 | 50.85 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 100/218 ， 74/218。
[{"date":"2025-06-30","value":"-9.47","vol":"79.06"},{"date":"2025-03-31","value":"-0.46","vol":"-0.84"},{"date":"2024-12-31","value":"-36.67","vol":"17.88"},{"date":"2024-09-30","value":"-46.79","vol":"45.69"},{"date":"2024-06-30","value":"-46.76","vol":"710.38"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-9.47 | -0.46 | -36.67 | -46.79 | -46.76 |
| 行业(%) | 79.06 | -0.84 | 17.88 | 45.69 | 710.38 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.47","vol":"56.66"},{"date":"2025-03-31","value":"-960.04","vol":"-21.21"},{"date":"2024-12-31","value":"164.51","vol":"-21.14"},{"date":"2024-09-30","value":"-37.65","vol":"-32.33"},{"date":"2024-06-30","value":"-157.30","vol":"8.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
1.47 | -960.04 | 164.51 | -37.65 | -157.30 |
| 行业(%) | 56.66 | -21.21 | -21.14 | -32.33 | 8.14 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 69/218 ， 47/218。
[{"date":"2025-06-30","value":"0.20","vol":"0.21"},{"date":"2025-03-31","value":"0.11","vol":"0.10"},{"date":"2024-12-31","value":"0.42","vol":"0.43"},{"date":"2024-09-30","value":"0.28","vol":"0.33"},{"date":"2024-06-30","value":"0.19","vol":"0.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.20 | 0.11 | 0.42 | 0.28 | 0.19 |
| 行业(次) | 0.21 | 0.10 | 0.43 | 0.33 | 0.23 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.39","vol":"1.32"},{"date":"2025-03-31","value":"0.73","vol":"0.67"},{"date":"2024-12-31","value":"2.85","vol":"3.24"},{"date":"2024-09-30","value":"2.00","vol":"2.18"},{"date":"2024-06-30","value":"1.28","vol":"1.51"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.39 | 0.73 | 2.85 | 2.00 | 1.28 |
| 行业(次) | 1.32 | 0.67 | 3.24 | 2.18 | 1.51 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 131/218 ， 2/218。
[{"date":"2025-06-30","value":"-15.76","vol":"2.81"},{"date":"2025-03-31","value":"11.44","vol":"-28.76"},{"date":"2024-12-31","value":"-23.45","vol":"-371.46"},{"date":"2024-09-30","value":"7.03","vol":"-9.87"},{"date":"2024-06-30","value":"7.63","vol":"-253.98"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -15.76 | 11.44 | -23.45 | 7.03 | 7.63 |
| 行业 | 2.81 | -28.76 | -371.46 | -9.87 | -253.98 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.04","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.05","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.05","vol":"2.19"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.04 | - | 0.05 | - | 0.05 |
| 行业 | 1.73 | 0.00 | 1.99 | 0.00 | 2.19 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 108/218 ， 86/218。
[{"date":"2025-06-30","value":"0.19","vol":"3.66"},{"date":"2025-03-31","value":"0.24","vol":"3.59"},{"date":"2024-12-31","value":"0.25","vol":"3.32"},{"date":"2024-09-30","value":"0.20","vol":"3.66"},{"date":"2024-06-30","value":"0.17","vol":"3.59"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.19 | 0.24 | 0.25 | 0.20 | 0.17 |
| 行业 | 3.66 | 3.59 | 3.32 | 3.66 | 3.59 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.12","vol":"2.88"},{"date":"2025-03-31","value":"0.17","vol":"2.81"},{"date":"2024-12-31","value":"0.19","vol":"2.63"},{"date":"2024-09-30","value":"0.12","vol":"2.92"},{"date":"2024-06-30","value":"0.11","vol":"2.88"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.12 | 0.17 | 0.19 | 0.12 | 0.11 |
| 行业 | 2.88 | 2.81 | 2.63 | 2.92 | 2.88 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 147/218 ， 1/218。
[{"date":"2025-06-30","value":"105.23","vol":"33.92"},{"date":"2025-03-31","value":"102.85","vol":"34.04"},{"date":"2024-12-31","value":"101.61","vol":"34.34"},{"date":"2024-09-30","value":"121.86","vol":"33.02"},{"date":"2024-06-30","value":"120.09","vol":"33.19"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
105.23 | 102.85 | 101.61 | 121.86 | 120.09 |
| 行业(%) | 33.92 | 34.04 | 34.34 | 33.02 | 33.19 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"19.32","vol":"0.89"},{"date":"2025-03-31","value":"13.58","vol":"1.46"},{"date":"2024-12-31","value":"11.68","vol":"0.84"},{"date":"2024-09-30","value":"","vol":"0.73"},{"date":"2024-06-30","value":"","vol":"0.71"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
19.32 | 13.58 | 11.68 | - | - |
| 行业(%) | 0.89 | 1.46 | 0.84 | 0.73 | 0.71 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"-1.53","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-1.23","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-2.36","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.52","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]